VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Thursday, January 8, 2026
Stock Comparison
Dino Polska S.A. vs Novartis AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Dino Polska S.A.
DNP · Warsaw Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Dino Polska S.A.'s moat claims, evidence, and risks.
View DNP analysisNovartis AG
NOVN · SIX Swiss Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novartis AG's moat claims, evidence, and risks.
View NOVN analysisComparison highlights
- Moat score gap: Dino Polska S.A. leads (66 / 100 vs 65 / 100 for Novartis AG).
- Segment focus: Dino Polska S.A. has 1 segment (100% in Proximity grocery retail (Dino stores)); Novartis AG has 5 segments (29.3% in Oncology).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Weak vs Strong.
- Moat breadth: Dino Polska S.A. has 5 moat types across 2 domains; Novartis AG has 4 across 3.
Primary market context
Dino Polska S.A.
Proximity grocery retail (Dino stores)
Retail grocery (mid-sized proximity supermarkets)
Poland
Households / consumers
Brick-and-mortar grocery retailer
100%
Novartis AG
Oncology
Oncology and hematology branded medicines (including targeted therapies and radioligand therapy)
Global
Oncologists and hospitals; reimbursed by payers; hospital and specialty pharmacy channels
Originator developer, manufacturer, and marketer of oncology therapies
29.3%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Dino Polska S.A. strengths
Novartis AG strengths
Segment mix
Dino Polska S.A. segments
Full profile >Proximity grocery retail (Dino stores)
Oligopoly
Novartis AG segments
Full profile >Cardiovascular, Renal and Metabolic
Oligopoly
Immunology
Oligopoly
Neuroscience
Oligopoly
Oncology
Oligopoly
Established Brands
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.